Teleflex Continues Restructuring By Selling Hudson Respiratory Business To Medline
Medline will pay $286m in cash for Teleflex's oxygen and aerosol therapy, active humidification, and non-invasive ventilation devices as well as incentive spirometers. Those businesses yielded $139m in 2020 revenues, but do not fit into Teleflex's plan for the future.
You may also be interested in...
Medline Industries has issued a recall of some of its saline solution products for being non-sterile. The US FDA has designated the recall class I.
Z-Medica’s wound care products, led by its QuikClot Control+ hemostatic dressing, complement Teleflex’s existing line of products marketed to first responders and the military.
Medtronic will stop producing ventilators and combine the rest of its patient monitoring and respiratory interventions business into a new business called acute care and monitoring. The company had previously announced plans to divest all of the patient monitoring and respiratory intervention business.